| α | Alpha |
| β | Beta |
| CAH | Congenital adrenal hyperplasia |
| CDC | Centers for Disease Control and Prevention (U.S.) |
| CE | Capillary electrophoresis |
| CH | Congenital hypothyroidism |
| CHGS | Center for Human Genetic Services |
| CNSP | California Newborn Screening Program (U.S.) |
| DOH | Department of Health (national health agency - Philippines) |
| G6PD | Glucose-6-phosphate dehydrogenase |
| GAL | Galactosemia |
| Hb | Hemoglobin |
| HCY | Homocystinuria |
| HPLC | High performance liquid chromatography |
| MSUD | Maple syrup urine disease |
| NBS | Newborn bloodspot screening |
| NBSCC | Newborn screening continuity clinic (long-term follow-up - Philippines) |
| NNSGRC | National Newborn Screening and Global Resource Center (U.S.) |
| NSC | Newborn Screening Center (screening laboratory - Philippines) |
| NSF | Newborn Screening Facility (screening specimen collection site - Philippines) |
| NSQAP | Newborn Screening Quality Assurance Program (U.S.) |
| NSRC | Newborn Screening Reference Center (Philippines) |
| PhilHealth | Philippine Health Insurance Corporation (national health insurance) |
| PKU | Phenylketonuria |
| POGS | Philippine Obstetrical and Gynecological Society |
| PPS | Philippine Pediatric Society |
| PT | Proficiency testing |
| QC | Quality control |
| SCD | Sickle cell disease |